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Abstract Bone grafting is one of the commonest surgical procedures, yet all bone substitutes
developed so far suffer from specific weaknesses and the search for a bone graft material with
ideal physical and biological properties is still ongoing. Calcium phosphate pastes are the most
frequently used synthetic bone grafts, yet they (a) often take an impractically long time to set, (b)
release the drug content too fast, and (c) do not form pores large enough to accommodate host cells
and foster osseointegration. To make up for these deficiencies, we introduced gelatin and silica to
pastes composed of 5–15 nm sized hydroxyapatite nanoparticles and yielded a bioresorbable
composite that is compact, yet flowing upon injection; that prevents setting at room temperature,
but sets promptly, in minutes, at 37 oC; that displays an increase in surface porosity following
immersion in physiological fluids; that allows for sustained release of antibiotics; and that sets in
a tunable manner and in clinically relevant time windows: 1-3 minutes at its fastest. Timelapse, in
situ X-ray diffraction analysis demonstrated that the setting process is accompanied by an increase
in crystallinity of the initially amorphous hydroxyapatite, involving no polymorphic phase
transitions in its course. Setting time can be tuned by controlling the weight content of gelatin or
powder-to-liquid ratio. The release of vancomycin was slow, ~ 8 % after 2 weeks, and unaffected
by the gelatin content. While vancomycin-loaded pastes were effective in reducing the
concentration of all bacterial species analyzed, the bacteriostatic effects of the antibiotic-free
pastes were pronounced against S. liquefaciens and E. coli. S. liquefaciens bacilli underwent
beading and filamentation during the treatment, suggesting that the antimicrobial effects are
attributable to cell wall disruption by hydroxyapatite nanoparticles. Vancomycin-loaded pastes
augmented the activity of the antibiotic against P. aeruginosa and S. liquefaciens, while exhibiting
no negative effects against human mesenchymal stem cells. They were also uptaken three times
more abundantly than pure hydroxyapatite, indicating the theoretical favorability of their use for
intracellular delivery of therapeutics. This selectivity, toxic for bacteria and harmless for primary
stem cells, is promising for application as bone grafts for osteomyelitis.
Keywords: Antibacterial; Bone graft; Cement; Composite; Hydroxyapatite; Nanoparticles.
1. Introduction
Eight million non-maternal and non-neonatal operating room procedures are performed
annually in the US and five out of seven most common ones target the musculoskeletal system1,
the majority of which involve the use of bone grafts to reconstruct hard tissue defects. Despite this,
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deficiencies are associated with all the marketable bone substitutes and the search for a bone graft
material with ideal physical and biological properties is ongoing2. Autologous bone, for one,
despite its obvious demerits, still presents the gold standard for bone grafts3. However, it
necessitates a secondary surgical procedure for its extraction, typically from the donor’s iliac crest,
fibula or mandibular symphysis. This increases not only the procurement cost and the operative
time, but also the chances for postsurgical complications, the patient’s discomfort, unaesthetic
disfigurements and the overall extraction site morbidity. Bovine derivatives and other xenografts
have been used as regular alternatives in the clinic4, but they increase the risk of infection and
immunogenic response and are, like autografts and allografts, subject to variability in composition
and properties, leading to significant uncertainties regarding the clinical outcome. Inconsistent
osseous incorporation is, thus, a frequent result of autogenous and xenogeneic bone grafting
procedures5. Moreover, for some localities, particularly the load-bearing ones, such as foot and
ankle, systematic metastudies indicate no statistically significant benefit of autografts and other
naturally derived grafts over no graft at all6. Natural in origin, such grafts also allow for little
control over the material properties and their in situ adjustment to the bone void location and
geometry. Rich in the biomolecular content, biological grafts are also tied to the problem of
destructive sterilization, which often contaminates or modifies the material properties in random
and unpredictable ways, leading to increased risk of failure7. All of this necessitates the quest for
viable synthetic alternatives to these biological extracts.
On the physical side, ideal synthetic bone and articular grafts should be moldable in
clinically relevant timespans, bind to bone well and have a sufficient mechanical stability, yet
degrade with rates that match the new tissue ingrowth, typically ranging from a few weeks to
months. On the biological side, ideal synthetic bone and articular grafts, like most biomaterials in
general, should possess a sufficient bioactivity and elicit a positive response from the tissue that
they come in contact with. To that end, the bone graft should be osteoconductive in terms of being
able to attract and induce proliferation of bone cells; osteoinductive in terms of being able to
promote the differentiation of osteoprogenitor and pluripotent mesenchymal cells into osteoblasts;
and ossointegrative in terms of being able to enter a stable union with the bone tissue that it is
being grafted to. The use of hydroxyapatite (HAp) and/or other calcium orthophosphates (CPs)
presents a standard approach to endowing a bone graft with sufficient bioactivity and compressive
strength8. Out of a dozen different CP phases, HAp presents a typical phase of choice because of
its being the least soluble9, the most bioactive10 and the most mechanically stable11 of them all,
alongside being the natural mineral component of mammalian hard tissues. Pure CP grafts can also
be made in a self-setting form, viscous upon the implantation or injection and hardening
thereafter12. However, the setting timescales of pure CP pastes often extend beyond the ideal
therapeutic window that is minutes in range, especially for larger graft volumes13. At the same
time, pure CP pastes set in relatively dense forms14,15, extending their resorption rate beyond the
optimal range that is a few weeks in duration and offering no control over their porosity16, which
is essential in enabling the bone substitute to mimic the extracellular matrix of bone and provide
conditions for infiltration and proliferation of the host cells17, permeation of the blood plasma and
vascularization, thus fostering the osseointegration process.
An immediate advantage of CP grafts is the ability to achieve sustained, locally delivered
release of antibiotics into avascular areas that are otherwise inaccessible to systemically
administered drugs18. However, pure self-setting CP pastes developed in our earlier study19, albeit
offering in situ tunable drug release profiles, released antibiotics in the first 2 weeks of immersion
in a body fluid. This short duration of the release contrasts the timeline of a typical antibiotic
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therapy for chronic osteomyelitis, consisting of 2 weeks of systemic administration on average and
being followed by a 6-month course of oral antibiotics20,21. To overcome all three of these critical
issues, we have introduced gelatin-silica hybrid as an additional component to HAp nanoparticles
comprising the pastes developed earlier. The biomimetic choice of HAp and gelatin in the weight
ratios ranging from 70 – 77 wt.% and 19 – 26.5 wt.%, respectively, is justified by (a) bone being
a composite material, containing approximately 70 wt.% of the mineral, apatite phase, 22 wt.% of
collagenous proteins, 5 wt.% of water and 3 wt.% of noncollagenous proteins and other
biomolecules22, and (b) gelatin being collagenous in origin, water-soluble and thus more easily
formable into a composite form together with HAp23 than native collagen24. Previous addition of
gelatin to porous constructs made of electrospun poly(ε-caprolactone) fibers and supplemented
with HAp increased their bioactivity, specifically cell adhesion and proliferation25. The
combination of methacrylated gelatin and silica also allowed for the fabrication of a porous and
photocurable hydrogel with good mechanical and biological properties26. By introducing this soft
component, we, first of all, attempt to provide a biosoluble constituent that would create pores
upon contact with the aqueous medium and be the basis for an injectable tissue engineering
construct27. Secondly, the role of the additional component is to sustain the release of antibiotics
for prolonged periods of time and enable the graft to act either prophylactically or therapeutically,
as an antimicrobial bone substitute. And thirdly, the role of this additional component is to shorten
the setting timescale from 30 – 45 minutes for relatively large graft geometries down to 2 – 10
minutes, while at the same time decreasing their viscosity and facilitating flow through the syringe
during injection. The role of silica as a minor additive was similarly threefold. First, it was to act
as a colloidal stabilizer due to silanization28,29 and, thus, improve the paste flow. Secondly, it was
to act as a moderate foaming agent and thus contribute to pore formation. Finally, it was to act as
a nucleation agent to further accelerate the setting process initiated by gelation of gelatin at 37 oC
and the liberation of the HAp grain surface. In total, the goal of the present study is dual: it is to
provide a fundamental insight into the properties and the mechanism of (trans)formation of the
material through its precise characterization, but also assess its applicative potentials as a
biomaterial through assaying in vitro.
2. Materials & Methods
2.1. Synthesis
Aqueous polymer solutions containing either 5 wt.% (composition 1, Table 1) or 7.5 wt.%
(composition 2, Table 1) of porcine-skin-derived type A gelatin (Sigma) and having the volume of
25 ml were prepared and 25 mg of vancomycin (M.P. Biomedicals) were added to them, followed
by the addition of 500 μl of tetraethylorthosilicate (TEOS, Sigma). In another container, 3 ml of 1
M NH4H2PO4 (aq.) (Fisher Scientific) were added dropwise to 2.5 ml of 2 M Ca(NO3)2 (aq.)
(Fisher Scientific), followed first by the addition of 9 ml of concentrated, 28 % NH4OH (Sigma
Aldrich) to raise the pH and then by the addition of 85 ml of deionized, Millipore water. The
resulting milky suspension containing HAp nanoparticles was stirred with the magnetic bar and
brought to boil, at which point it was poured into the polymer solution while stirring at 400 rpm.
The colloidal mixture then had 5 ml of 3 mg/ml aqueous solution of vancomycin added to it while
stirring. The colloid was sedimented by centrifugation and washed with deionized water. The
resulting precipitate was dried overnight in vacuum (- 25 mmHg, Savant SPD1010 Speedvac
concentrator). Unless otherwise noted, the dried composite powders crushed in a mortar down to
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fine particle size were mixed with a liquid phase in 0.33 mg/μl powder-to-liquid (P/L) ratio to yield
the paste-like formulations. An aqueous solution of NaH2PO4 (2 wt.%, Fisher Scientific) was used
as the liquid phase unless otherwise noted. The manual mixing proceeded by adding the powder
gradually to the liquid phase while stirring with a spatula so as to preserve the formulation in the
pasty state. Following the mixing of the solid and the liquid phase, the paste was vortex-mixed in
1.5 ml Eppendorf tubes for 5 min at 2000 rpm, then poured onto a plastic Petri dish and allowed
to set at either 25 oC or 37 oC. Vortex-mixing was performed in almost full Eppendorf tubes to
minimize the exposure to air and the dissipation of the paste on the tube walls. The simplified
schematics of the synthesis protocol is shown in Fig.1. Assuming that the precipitation,
condensation and capture of HAp/gelatin, silica and vancomycin, respectively, were complete, the
estimated two composite paste compositions, whose precursors differed only in the
abovementioned amount of gelatin (5 and 7.5 wt.% in the precursor gelatin solution), are listed in
Table 1. Table 2 lists the vancomycin loading efficiency in the two compositionally different
pastes. Per Eq.1, the loading efficiency (LE), equivalent to the weight percentage of vancomycin
in the final composition, was measured by normalizing the weight of the encapsulated drug (md)
to the total weight of the carrier (mc). The drug content (md) was determined by measuring the
absorbance on a UV/Vis spectrophotometer (Nanodrop 2000, Thermo Scientific) at λ = 200 nm.
LE = md/mc x 100 (%)

(Eq.1)

Table 1. The two composite paste compositions analyzed, differing most critically in their weight contents of gelatin:
19.4 and 26.5 wt.%.

Composition
1
2

HAp (wt.%)
77.4
70.5

Gelatin (wt.%)
19.4
26.5

Silica (wt.%)
3.2
3.0

Table 2. Vancomycin loading efficiency for the two types of composite pastes.

Composition
1
2

Loading efficiency (wt.%)
10
8.8
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Fig.1. Schematic representation of the major steps in the synthesis of the self-setting HAp/gelatin/silica composite
paste.

2.2. Physicochemical characterization
Scanning electron microscopy (SEM) studies were carried out on a JEOL JSM 6320FFESEM operated at 3.2 kV voltage and 8 𝜇A beam current. Sample preparation involved
depositing powders or pastes on clean aluminum stubs using the carbon tape and sputter-coating
them with gold to reduce the surface charging effects. X-Ray diffraction (XRD) studies were
carried out on a Bruker D2 Phaser diffractometer using polychromatic Cu as the irradiation source.
Kβ line was stripped off with an inbuilt filter, whereas Kα2 line was stripped off manually. The step
size and the irradiation time per step were 0.01 o and 1 second for the regular measurements and
0.02 o and 0.3 seconds for the timelapse ones. Particle size distribution of the composite HApgelatin-silica pastes dispersed in water was analyzed using a Malvern Zetasizer dynamic light
scattering analyzer. Transmission electron microscopy (TEM) studies were performed on a JEOL
JEM 1220 Life Science TEM operated at 80 kV.
2.3. Setting time determination
To determine the setting time variations based on the polymer content in the composite
pastes, two different gelatin concentrations (19.4 wt.% and 26.5 wt.%) were used to synthesize the
pastes. The setting time of the samples was divided to two categories: the initial setting time and
the final setting time. The measurements were done in accordance with ISO 1566. The standard
Vicat needle method (ASTM C191-92) was used on samples placed in 47 mm plastic Petri dishes
(Fisherbrand) and incubated at 37 oC. The sample was considered initially set when the needle
(30G hypodermic disposable needle, EXEL International) made a slight circular indentation on the
surface of the sample, but was far from the bottom. The final setting time was noted when the
needle failed to make any visible indentation on the sample surface.
2.4. Drug release assay
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Vancomycin-loaded pastes were allowed to completely set before they were placed in 50
ml of phosphate buffered saline (PBS) in closed conical tubes and incubated at 37 °C and 50 rpm
rotation perpendicular to the cylinder axis. The drug release rates were determined in duplicates
by taking 1 ml PBS on daily basis for two weeks. The volume of the aliquoted solution was
replaced each time with fresh PBS. The drug content was determined spectrophotometrically, as
described in Section 2.1.
2.5. Antibacterial assay
In the liquid inoculation test of the vancomycin-containing samples, a single colony of
Staphylococcus aureus cultured on a blood agar plate over a period of 24 h was stabbed with a
pipette tip and placed in 5 ml of brain heart infusion broth (Sigma Life Sciences) and incubated
overnight at 37oC and 170 rpm. The same procedure was repeated for Escherichia coli, Serratia
liquefaciens, Salmonella entiritidis, and Pseudomonas aeruginosa, all of which were cultured on
nutrient agar plates and inoculated in the nutrient broth (Sigma Life Sciences). Twenty-five
microliters of pastes were added to the infected broths. All the samples were analyzed in
duplicates. Antibiotic-loaded pastes were compared against sets of three controls: one negative
control contained 5 ml of the broth in which a single colony of a bacterium was introduced and
then incubated for 24 h; the second negative control had the pastes containing no antibiotic added
to the bacterially infected broth in order to determine the antibacterial efficacy of the sole paste;
the positive control had the antibiotic added to the bacterially infected broth in the same amount
as that contained in the 25 μl of the paste, i.e., 2.5 mg for the 19.4 wt.% gelatin-containing paste
and 2.2 mg for the 26.5 wt.% gelatin-containing paste. Staining of bacteria with crystal violet and
safranin was performed with a gram-staining kit (Sigma-Aldrich) applied on glass slides following
an overnight treatment with the composite pastes.
2.6. hMSC viability assay
A 12 mM 3-[4, 5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) stock
solution was prepared by adding 1 ml of sterile PBS to a 5 mg vial of MTT and vortex-mixing to
ensure complete dissolution. Earlier, human mesenchymal stem cells (hMSCs, courtesy of Anne
George, University of Illinois at Chicago) were seeded at the concentration of 5 x 103 cells/well in
a 96-well plate and 2 𝜇l of the composite HAp pastes were added to each well. The cells were
incubated with the pastes for 24 hours in 100 𝜇l of the general hMSC culture medium without
ascorbic acid (StemPro MSC SFM) and 10 wt.% fetal bovine serum (FBS). After the given
incubation period, the culture media were replaced by 100 𝜇l of the fresh media of the same
composition. Then, 10 𝜇l of the 12 mM MTT stock solution were added to each well containing
the pastes as well as to the control wells. This was followed by incubation at 37 oC for 4 hours.
Subsequently, the cell culture medium in each well was removed until 25 𝜇l/well remained. Then,
50 𝜇l of dimethyl sulfoxide (DMSO) was added to each well and mixed in with a pipette tip. The
well plate was incubated again at 37 oC for 10 minutes, after which the samples were mixed again
and absorbance values were measured at λ = 540 nm. The positive control consisted of the cells
with the growth medium, while the negative control contained only the growth medium without
the cells. All the samples, including the controls, were analyzed in triplicates and their absorbance
values were normalized to the absorbance of the negative control.
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hMSc grown on glass coverslips in 24-well plates in the general hMSC culture medium with
10 wt.% FBS were treated with 5 mg/ml of either HAp or HAp-gelatin-silica paste and incubated
for 24 h. The cells washed with PBS and fixed for 5 minutes in 4% paraformaldehyde, before being
rewashed with PBS and incubated with Alexa Fluor 568 Phalloidin (1:400) (Molecular Probes)
and OsteoImageTM bone mineralization staining agent (Lonza) for 30 minutes. Cells were then
washed 3 times with PBS and cell nuclei were counterstained using NucBlue fixed cell
ReadyProbe reagent (Molecular Probes) for 20 minutes. Images were obtained using a Nikon T1S/L100 inverted epifluorescent confocal microscope. All the samples were analyzed in duplicates.
3. Results and discussion
The pastes were composed of uniformly dispersed, ultrafine HAp nanoparticles with sizes
in the 5 – 15 nm range (Fig.2a). The narrowness of this primary particle size distribution is seen
from the histograms obtained from SEM measurements (Fig.3a). The confinement of these
primary particles inside the polymeric matrix increases the hydrodynamic particle size up to ~ 200
nm (Fig.3b). TEM imaging was used to visualize the polymeric matrix enveloping the
nanoparticles inside larger units (Fig.2b). Zeta potential (ζ) of the colloidal suspensions of particles
in water as the function of pH is shown in Fig.4. The ±15 mV is typically considered the threshold
for colloidal stability30, yet for both HAp and HAp-gelatin-silica particles, the zeta potential was
found in the - 20 < ζ < 15 mV range, indicating little to no conditions for colloidal stability except
in the pronounced acidic range, at pH < 3, where the dissolution of HAp is copious, if not complete.
Zeta potential of pure HAp in water was particularly low under physiological conditions, < 5 mV,
suggesting the strong propensity for aggregation. This propensity became lowered following the
addition of the negatively charged gelatin and silica. As a result, zeta potential in the physiological
pH range was pushed towards more negative values, specifically from 3.27 mV for pure HAp to –
0.06 mV for the HAp composite containing 19.4 wt.% gelatin to – 7.48 mV for the HAp composite
containing 26.5 wt.% gelatin. The points of zero charge correspondingly decreased following the
addition of gelatin-silica to HAp (Fig.4).

Fig.2. SEM (a) and TEM (b) image of set HAp-gelatin-silica pastes showing the presence of HAp nanoparticles (a)
and their encapsulation within an amorphous, polymeric gelatin/silica shell (b).
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Fig.3. SEM-derived particle size distribution histogram for HAp nanoparticles comprising the composite HAp-gelatinsilica pastes (a) and DLS-derived average particle size of the composite HAp-gelatin-silica pastes with two different
gelatin contents, 19.4 and 26.5 wt.%, suspended in water (b). Data are shown as averages with error bars representing
standard deviation.

Fig.4. Zeta potential vs. pH curves for HAp nanoparticles comprising the composite HAp-gelatin-silica pastes and for
the composite HAp-gelatin-silica pastes containing 19.4 and 26.5 wt.% of gelatin. Points of zero charge (PZC) are
denoted in the graph. Data are shown as averages with error bars representing standard deviation.

The fresh pastes prepared in situ by mixing the solid and the liquid component set in
clinically ideal timespans. The pastes can be mixed in powder-to-liquid (P/L) ratios to allow for
setting times ranging from 1 to 20 minutes for the initial setting times and from 3 to 25 minutes
for the final setting times (Fig.5a-b). These times show direct dependence on the weight content
of the gelatin component of the paste. As the gelatin content at P/L = 0.33 mg/μl increases from
19.4 to 26.5 wt.%, so does the initial setting time increase from 2.3 to 3.6 minutes and the final
setting time from 5 to 8 minutes (Fig.5a). As in partial agreement with a previous report31, gelatin
added to CP pastes shortens the span between the initial and the final setting time. At the same
time, the P/L ratio demonstrates an inverse proportionality to the setting times (Fig.5b). As it
increases from 0.1 to 0.5 mg/μl, the initial setting times drop from 20 to 1 minute and the final
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setting times drop from 25 to 3 minutes. Below this range the pastes are too dilute to allow for the
close particle-particle contact and the entwinement of the growing HAp crystals in the setting
stage. Since this is what defines the solidity of the hardened paste, excessively low P/L ratios (<
0.1 mg/μl in this case) directly translate to insufficient cohesiveness of the final product. Above
the given range (> 0.5 mg/μl) the grains comprising the paste are deprived of proper perfusion of
the liquid activator of the setting process, as the result of which no pervasive grain binding can
occur and the cohesiveness equally suffers. Within the range outlined in Fig.5b, 0.1 mg/μl < P/L
< 0.5 mg/μl, higher P/L ratios and shorter setting times coincide with greater cohesiveness and
geometric integrity of the final product. As a result, the less viscous pastes set slower, but are
injectable through smaller diameter hypodermic needles, coinciding with larger gauge numbers.
As seen from Fig.5b, all pastes are fully drawable into the syringe and extrudable using G20-24
hypodermic needles, although thicker pastes required lower G numbers. Pastes in the low G range
are moldable, but less prone to injection without causing the phase separation due to pressure
gradient issues. The setting reaction is, however, expected to be subject to minor variations
depending on the volume and the geometry of the paste. Lower volumes and geometries with
higher exposed surface area will, for example, set somewhat faster than their opposites, and the
difference can be as high as ± 50 % of the temporal values denoted in Fig.5b.
Bone is an organ whose functionally gradient structure displays a large variability between
the surface and the interior. For example, the cortical surface of long bones possesses a markedly
lower remodeling rate and porosity than the cancellous bone lying closer to the marrow32. This
poses the demand for grafts with tunable setting rates and the ability to match the local tissue
turnover and the vascular flux33. On top of this, the idea that zero-order release kinetics is ideal for
each drug delivery application has become obsolete and is gradually ceding place to the concept
of chronopharmacokinetics as the systematic adjustment of the release profiles to circadian and
other rhythmic flows of metabolites present in the target area34. Here we see that the setting times
of the HAp-gelatin-silica composite pastes can be tuned by controlling their gelatin content
(Fig.5a) and by controlling their P/L ratios (Fig.5b). As for the latter, an exponential, first-order
kinetics is associated with this effect and the linear fit of the logarithmic dependence of the final
setting time on P/L ratio gives a good correlation coefficient value (R2 = 0.93, Fig.5c), allowing
also for the calculation of the final setting time in minutes, t, for a given P/L ratio in mg/μg using
the following empirically derived equation:
t = 101.33 – 1.712(P/L)

(0.1 mg/μl ≤ P/L ≤ 0.5 mg/μl)

The phenomenon of directly proportional increase in the weight content of gelatin and the
duration of the setting reaction is the consequence of the fact that the phase transformation from
amorphous CP to crystalline HAp, governing the setting process, proceeds partially by following
the surface dissolution/reprecipitation mechanism. For this reason, for example, the timely
imposition of a solid polymeric coating around the freshly precipitated CP nanoparticles has the
ability to hamper their phase transition into a more crystalline and thermodynamically stable state,
freezing their structure in a comparatively amorphous and more active state 35. The same effect is
at play here: gelatin-silica component partially blocks the CP particle contact and the surface
diffusion of CP ionic growth units (Ca2+, PO43-, OH-), slowing down the crystallization process as
the result. Since a very small amount of gelatin is sufficient to block the particle surface and gelatin
does not set at 37 oC, any further increase in its content slows down the setting process, as
demonstrated by Fig.5a.
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This brings us over to perhaps the most interesting effect achieved by adding gelatin to
HAp: immobilized setting reaction at room temperature. A comparison between the setting times
at 25 and 37 oC is shown in Fig.5d, demonstrating that the pastes could be prepared in situ in a
clinical setting without concern that they might prematurely set. Implanted, however, and
introduced into a 37 oC environment, the setting reaction is activated and proceeds at clinically
ideal timespans, i.e., in a couple of minutes. Thus, for a composite HAp paste containing 19.4
wt.% gelatin and mixed with 2 wt.% NaH2PO4 in 0.5 mg/μg P/L ratio, the initial and the final
setting reactions end after 39 and 53 minutes, respectively, at room temperature, as opposed to
only 1 and 3 minutes at the physiological temperature (Fig.5c). As mentioned, solid gelatin coating
around CP nanoparticles retards the setting reaction that proceeds by following the
dissolution/recrystallization mechanism. However, gelatin undergoes gelation at 37 oC,
disentangling from CP grains and liberating their surface, thus effectively activating the setting
reaction.
To explain the faster setting of gelatin-containing pastes compared to pure HAp ones, a
catalytic role must be ascribed to gelatin. One possibility is that gelatin contributes with active
groups that serve as nucleation centers, accelerating the crystallization process that governs the
setting reaction. The minor presence of silica and/or silylation of gelatin prior to its admixing to
CP sol are supposed to augment the nucleation promotion capacity of gelatin alone and, together
with the effect of Si-O-Si polymerization36,37, speed up the setting reaction. The other possibility
is that gelatin as gel buffers the setting reaction by consuming the chemical potential imparted by
the liquid phase, accelerating the reaction as the result, but making it less complete, the evidence
of which may be the lower compressive strength of gelatin-containing HAp pastes compared to
the pure HAp ones. If this is correct, then gelatin, counterintuitively, plays a role antipodal to that
of a binder. In any case, the effect of gelatin on the setting reaction is apparently twofold. At low
concentrations, it speeds it up. Thus, at identical P/L ratios, the setting times are 7 – 8 times lower
when gelatin (19.4 wt.%) is added to the paste composition. At higher concentrations, however,
being a passive component from the hardening process standpoint, it slackens it by interfering with
dissolution/recrystallization intrinsic to the setting reaction. This is evidenced by the increased
setting time when the concentration of gelatin in HAp pastes is increased by approximately one
quarter, i.e., from 19.4 to 26.5 wt.% (Fig.5a).
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Fig.5. (a) Variation of the initial and the final setting times of HAp-gelatin-silica composite pastes depending on: (a)
the content of gelatin in pastes with powder-to-liquid ratio (P/L) of 0.33 set at 37 oC using 2 wt.% NaH2PO4 as the
liquid phase; (b) P/L ratio in 60 μl 19.4 wt.% gelatin-containing pastes set at 37 oC and 2 wt.% NaH2PO4 as the liquid
phase, along with the maximal hypodermic needle gauge numbers capable of extruding the paste in air for the given
P/L ratio ranges (b), the setting temperature of 60 μl 19.4 wt.% gelatin-containing paste with P/L = 0.5. The logarithmic
plot of the final setting time (minutes as units) of 19.4 wt.% gelatin-containing pastes in (b) as a function of P/L ratio
is shown in (c), along with the linear fit, the R2 value and the equation derived to correlate the setting time at 37 oC
with the P/L ratio. Data are shown as averages with error bars representing standard deviation.

The integrity and setting kinetics of the pastes differed depending on the chemical identity
and concentration of ions comprising the aqueous liquid phase. Thus, substituting Na+ with K+
speeds up the setting process, which is expected by knowing that Na+ is a more effective
substituent of Ca2+ in HAp than K+38 and, thus, a more potent inhibitor of its crystallization39,40,41,
the process intrinsic to the setting reaction. In turn, K+ solutions yield crumblier solids than Na+
ones, which can be explained by the fact that, although K+ and Na+ neighbor each other in the
Hofmeister series42, K+ is a less hydrated ion, meaning that its presence in the interfacial layer
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might interfere with the growing crystal entwinement by increasing the surface tension and
lowering the entropy of the hydration sphere compared to the effect exhibited by Na+. The
combination of the two ions in the liquid phase can partially make up for the weaknesses of both
of them alone, although the properties of the final product turn out to be highly dependent on
Na+/K+ molar ratios. Increasing the concentration of NaH2PO4 from 2 to 5 wt.% lowers the
brittleness and produces more viscous pastes which also set negligibly faster, whereas the same
change in the concentration for KH2PO4 increases the setting time, but produces no significant
change in mechanical integrity. The addition of vancomycin did not interfere significantly with
the setting reaction kinetics. Immersion of the set HAp composite paste containing 19.4 wt.%
gelatin in water for three weeks leads to partial degradation of the smooth and nonporous surface
of the hardened paste and dissolution of the water-soluble gelatin component, thus creating indents
and macropores (i.e., pores larger than 50 nm per IUPAC notation), the size of some of which is
sufficient to accommodate cells (Fig.6). The connection between the pores is, however, absent,
presenting a critical obstacle to the uninterrupted flux of nutrients and waste products in and out
of the structure and thus to the long-term internal population of the material with the cells.
Preventing the collapse of the hard, HAp component following the escape of the soft, gelatin
component is a challenge that needs to be solved before these pastes can be used as injectable
ceramic scaffolds. After three weeks of immersion, the set pastes visibly crack and dissipate, thus
fulfilling the requirement necessary to enable the substitution of the graft by the naturally ingrown
bone tissue over the typical period of three weeks. A direct correlation between porosity and poreforming ability of CP implants and their degradation and resorption rates was previously
established43,44. Also, as seen from Fig.6, pastes set with K+ ions in the liquid phase are more
dissipative, preserving shape to a lesser extent than pastes set in the presence of Na+.

Fig.6. SEM images of a set HAp-gelatin-silica composite paste prior (center) and after three weeks of incubation in
water (left and right), differing only in the liquid phase used in the paste formation stage: 2.5 wt.% K 2HPO4 and 1
wt.% NaCl (left) or 5 wt.% NaH2PO4 (right).

Fig.7 displays a difference in the X-ray diffractograms of a composite paste and of its two
major individual components, HAp (70.5 – 77.4 wt.%) and gelatin (19.4 – 26.5 wt.%). Gelatin is
detected in the precursor powder as an amorphous hump peaking at 2 = 20 o - 22 o. However,
neither of the two amorphous components, gelatin and silica, were detected in the XRD patterns
of the composite. Dry gelatin exhibited some level of crystallinity, which is being lost following
its reconstitution and mixing in with the HAp powder. Since HAp nanoparticles are precipitated
prior to their mixing with the organic and silica components, no significant change in the
crystallinity of the inorganic phase was observed. Fig.8 shows the changes in crystallinity of the
inorganic HAp phase throughout the first two hours following the onset of the setting reaction.
These timelapse XRD measurements evidenced that the setting process was accompanied only by
an increase in the crystallinity of the initially poorly crystalline HAp and not by a transformation
in the phase composition. Thus, only the most intense, (211) reflection of the hexagonal P63/m HAp
lattice is seen in the 30 – 41 o 2 range for the paste at time zero, immediately after the mixing of
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the solid and the liquid phase, as well as in the patterns taken during the following 8 minutes. Only
at the 10th minute does the noise due to amorphousness begin to subside and the (300) reflection
appears as a shoulder of the (211) reflection at 32.90 o as well as the (310) reflection at 39.86 o.
This is in accordance with our previous data on similar systems, showing that the setting of this
type of pastes is rare in a sense that it neither involves one of dicalcium phosphates, typically
brushite, as the end product nor does it involve tri-/tetra-calcium phosphates as precursors. Rather,
it is accompanied solely by a change in crystallinity. The setting reaction of the sample analyzed
using timelapse XRD was over in 15 minutes and this was reflected in the settling of the
crystallinity (Fig.8). An obvious increase in the absolute intensities (Fig.8a) as well as a reduction
in the background noise (Fig.8b) coincided with the detection of the final setting point. The fact
that no detectable changes in crystallinity were detected during the first 10 minutes of the setting
process suggests an autocatalytic route. The analysis of patterns in-between the initial and the final
setting time, i.e., in the 10 – 30 minute time range, indicated a finite degree oscillatory changes in
crystallinity (Fig.S1). Such oscillations between different equilibrium states in a liquid-to-solid
phase transition were previously noticed and attributed in origin to diffusive fluxes at the interface
between phases45. Oscillations were also observed at the particle-solution interface during
precipitation and dissolution reactions and were correlated with autocatalysis or reaction inhibition
by the product formation46. In the absence of a constant influx of the driving energy for the
amorphous-to-crystalline transition and back, the oscillatory reaction eventually settles in an
equilibrium state47. Synchronization enabled by the local variations in the chemical potential48 due
to competing crystallization and dissolution reactions is responsible for sustaining the nonlinear,
oscillatory dynamics at the solid/liquid interface and can be tied to pattern formation, indirectly
explaining the co-evolution of CP and the higher organisms. Here it is worth noting that the
transformations in the solid phase entailing the setting process and involving changes in
crystallinity exceed in duration the time length of the mechanical aspect of the setting process and
that the thermal energy under ambient conditions continues to stabilize the crystalline phase over
time. As a result, prolonged storage of the precursor powder can hinder the cement formation
process by blocking the temporary restoration of the amorphous phase on which this process
depends.
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Fig.7. XRD patterns of a composite HAp-gelatin-silica paste and of its major two individual components: HAp and
gelatin. Reflections derived from HAp are marked with .
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Fig.8. Timelapse XRD patterns of the composite, vancomycin-loaded HAp-gelatin-silica pastes containing 26.5 wt.%
of gelatin in the course of the setting process taking 15 minutes to reach the final setting time. Patterns were taken in
the course of 120 min following the initiation of the setting reaction and are plotted with both absolute (a) and relative
(b) diffraction intensities.

Fig.9. Vancomycin release profiles of HAp-gelatin-silica pastes containing different amounts of the gelatin
component: 19.4 and 26.5 wt.%. The last two data points for the 26.5 wt.% gelatin system are the result of extrapolation
of the preceding portion of the curve. Data are shown as averages with error bars representing standard deviation.

Unlike the setting time, tunable as a function of the gelatin content (Fig.5a) or the P/L ratio
(Fig.5b-c), the rate of release of vancomycin from the pastes immersed in SBF showed no
dependence on the weight ratio of gelatin in the composite (Fig.9). In our previous study, we
demonstrated that the weight ratio between two HAp components in a self-setting paste can be
used to tune both the setting rate and the rate of release of different antibiotics. In this study we
see no effect of the variation of the weight proportion between the two major components of the
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paste, HAp and gelatin, on the release kinetics. Still, for both composite pastes analyzed (Fig.9),
the release is slower and more sustained than that achieved from pure HAp pastes. Extrapolation
of the release profiles toward the data point of complete, 100 % release suggests that it would take
approximately a year for the release of vancomycin to reach completion. The fact that the drug
release kinetics is independent on the content of gelatin suggests that the release is controlled
through the affinity of vancomycin for HAp. In other words, vancomycin is expected to bind
primarily to the surface of HAp through electrostatic attraction and be released by overcoming this
attraction with the help of the hydration force. The parallel increase in vancomycin loading
efficiency and the weight percentage of HAp in the paste (Tables 1 and 2), by the same factor of
1.1, supports the idea that vancomycin predominantly gets adsorbed onto HAp instead of being
entrapped by gelatin. Still, by coating HAp grains and hindering the desorption of the drug, gelatin
allows for its slower and more sustained release. With the first week of release yielding a linear,
concentration-independent, zero-order profile and showing no signs of burst release, there is a
concern that this type of release may not exceed the minimal inhibitory concentration (MIC) and
will favor the rise of resistance to the antibiotic therapy among the pathogens. On one hand, to
deepen this question, we performed the antibacterial testing of the composite pastes in vitro. On
the other hand, with the release totaling ~ 2 % of the total drug content in the first 24 h, equaling
2 mg/g of the paste, it would take only 1 g/dm3 of the paste to reach the uppermost end of the MIC
for vancomycin against methicillin-resistant S. aureus (2 μg/ml)49 in this period of time. Such an
absence of the burst release indicates that the antibiotic is almost completely confined to the
interior of the hardened paste and that the degradation of the paste in an aqueous environment will
precondition its antibacterial activity. Although it is probable that a small amount of antibiotic will
settle on the surface of the paste upon its setting, it is also hardly conceivable that this amount
would be sufficient to cause an antibacterial effect that is markedly microbicidal and not purely
prophylactic.
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Fig.10. Bacterial population in a liquid inoculation assay of vancomycin-free composite HAp pastes containing 19.4
wt.% gelatin (Sample), vancomycin-loaded composite HAp pastes containing 19.4 wt.% gelatin (Sample + V) and
pure vancomycin (V) against (a) S. aureus, (b) S. enteritidis, (c) S. liquefaciens, (d) P. aeruginosa and (e) E. coli.
Assays were carried out after days 1, 2, 3, 6 and 7. Data are shown as averages with error bars representing standard
deviation. Data points significantly lower in value compared to the untreated control (far left, p < 0.05) are topped
with an asterisk. Asterisks topping the lines connecting individual data points from the Sample + V group with the
corresponding data points from the V group denote the significantly lower (p < 0.05) values in the former group
compared to the latter.
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Fig.11. Bacterial population in a liquid inoculation assay of vancomycin-free HAp pastes containing 26.5 wt.% gelatin
(Sample), vancomycin-loaded composite HAp pastes containing 26.5 wt.% gelatin (Sample + V) and pure vancomycin
(V) against (a) S. enteritidis, and (b) P. aeruginosa. Assays were carried out after days 1, 2, 3, 6 and 7. Data are shown
as averages with error bars representing standard deviation. Data points significantly lower in value compared to the
untreated control (far left, p < 0.05) are topped with an asterisk. Asterisks topping the lines connecting individual data
points from the Sample + V group with the corresponding data points from the V group denote the significantly lower
(p < 0.05) values in the former group compared to the latter.

Nanostructured drug delivery carriers are known for their ability to enhance the antibiotic
therapies50 and their role is expected to be especially prominent against intracellular pathogens51.
Vancomycin-loaded composite pastes were effective in reducing the concentration of all five types
of bacteria analyzed in this study: S. aureus, S. enteritidis, S. liquefaciens, P. aeruginosa, and
E.coli. Still, there was a notable difference in the activity: it was more pronounced against S.
aureus, S. liquefaciens and P. aeruginosa than against E. coli or S. enteritidis. The antibioticloaded pastes were also more effective than the pure, antibiotic-free pastes against the grampositive S. aureus on all 7 days; against the gram-negative S. entiritidis on day 3 for the composite
HAp paste containing 19.4 wt.% gelatin and days 1-2 and 6-7 for the HAp composite containing
26.5 wt.% gelatin; against S. liquefaciens on days 2 through 6; and against P. aeruginosa on days
1, 2, 3 and 7 for the HAp composite containing 19.4 wt.% gelatin and on all 7 days for the HAp
composite containing 26.5 wt.% gelatin (Figs.10-11). The antibacterial effects of pure, antibioticfree composite pastes were detected, but to a minor extent compared to the self-setting pastes
composed of HAp only and no gelatin-silica hybrid reported in our previous study. Clearly, the
antimicrobial effects of HAp pastes are, therefore, attributable to an interaction between HAp
nanoparticles and the bacterial cells, which becomes minimized following the encapsulation of
HAp nanoparticles in gelatin-silica matrix and their effective shielding from a direct contact with
the bacteria. With the biological interactions depending on the properties and the physical makeup
of both entities in interaction, it does not come as a surprise that the antibacterial effect of the pure
composite pastes, containing no antibiotics, were highly bacterium-dependent. Thus, whereas the
bacteriostatic effect of the pastes was pronounced against S. liquefaciens and E. coli, it was present
only at the earliest time points when tested against S. aureus, S. enteritidis, P. aeruginosa. With S.
aureus being a gram-positive bacterium and S. enteritidis and P. aeruginosa being gram-positive
bacteria, it is clear that the gram positive/negative dichotomy cannot be used in the context of
explaining the antibacterial activity of the pastes. Interestingly, whereas the bacterial count of S.
enteritidis and P. aeruginosa was reduced significantly for HAp pastes with 19.4 wt.% gelatin
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after days 1 – 2 and day 1, respectively (Fig.10), no significant reduction in the bacterial
concentration was observed when the same assay was run with HAp pastes containing 26.5 wt.%
gelatin (Fig.11). This is another direct evidence that the antibacterial effects of the composite
pastes are due to interaction between HAp nanoparticles and the bacteria, which becomes
mitigated when the nanoparticles become coated by gelatin-silica.

Fig.12. Optical images (a, b) and median lengths (c) of gram-stained S. liquefaciens bacilli having undergone no
treatment (a) and having been treated with HAp-gelatin-silica pastes. The destruction of bacteria proceeds in the
following steps: (1) filamentation through the formation of dimers and multimers; (2) increase in the filament aspect
ratio; (3) extensive aggregation; and (4) formation of necrotic spheroids. Data in (c) are shown as averages with error
bars representing standard deviation. The asterisk denotes an extremely statistically significant difference (P <
0.0001).

A comparison between the activity of pure vancomycin and vancomycin-loaded pastes led
to the observation of the ability of the pastes to augment the activity of vancomycin against specific
types of bacteria, such as P. aeruginosa (days 1 and 2 for both HAp composite with 19.4 wt.%
gelatin and HAp composite with 26.5 wt.% gelatin), E. coli (days 2 to 3 for the HAp composite
with 19.4 wt.% gelatin), and S. liquefaciens (days 1 through 6 for the HAp composite with 19.4
wt.% gelatin). The most intense antibacterial activity augmentation effect was seen against S.
liquefaciens, evident at all but the last, 7th day of the incubation time (Fig.10c). The treatment with
pure vancomycin had no effect on the bacterial count in the broths, but the treatment with the pure
composite pastes as well as with the vancomycin-loaded ones was able to keep the bacterial
concentration reduced for 3 and 6 days, respectively (Fig.10c). Following the interaction with the
composite pastes, S. liquefaciens bacilli undergo filamentation (Fig.12a-b) and the average length
of the viable bacteria, as shown in Fig.12c, changes from 1.3 to 2.1. In contrast to the rounding of
bacilli, which is the result of inhibited lateral wall peptidoglycan synthesis and the activation of
the septal wall peptidoglycan synthesis, their elongation is caused by the opposite effect. The
observed morphological changes thus indicate an effect on the cell wall as a possible mechanism
of action of the composite pastes. This is additionally supported by the fact that cell wall inhibitors
are typified by the formation of multimers in a stage preceding the filamentation52. Bacterial
elongation as the result of disrupted proteoglycan synthesis is a natural defense mechanism against
stress-inducing physicochemical agents, given that lengthened cells are more difficult to ingest
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and phagocytose by neutrophils53. As shown in Fig.12, the beading of the bacilli is succeeded by
the formation of continuous filaments and then by aggregation, lysis and formation of necrotic
spheroplasts, the transition to which increases with the duration of the treatment54. The inhibition
of penicillin-binding protein 3, which crosslinks proteoglycan exclusively at the septal, but not the
lateral wall, the inhibition of DNA synthesis through the SOS response and the inhibition of protein
and/or RNA syntheses have all been invoked as possible downstream causes of bacterial
filamentation55.
Previous studies have shown that HAp can destroy the cell wall of bacteria and induce K+
leakage, resulting in cell death56. This could be the mechanism by which the combination of HAp
as a carrier and vancomycin as the drug acts synergistically, endowing the antibiotic with a greater
antibacterial efficacy than that typifying it alone. The increased apoptotic effects of
chemotherapeutics following their delivery using CP nanoparticles were reported before57,58,59,60
and were attributed to other possible causes, including the sustained drug release enabled by the
CP carrier and the excessive calcium ion release61,62 capable of triggering the caspase-dependent
apoptotic pathway63,64 by permeabilizing the mitochondrion65. However, if the release of ions,
most critically Ca2+, is accepted as the mechanism for the augmentation of the toxic effect HAp
particles have on microorganisms, it would be difficult to explain numerous cases where
modifications of HAp particle properties affected the cell response even when their degradation
rates did not significantly change. One example comes from a study in which the particle size of
HAp affected the cell viability in such a way that 45 nm particles were more toxic than either 26
nm or 78 nm ones66. This is why we hypothesize that the penetration of the cell wall and the
intracellular delivery of the antibiotic is the key to explaining the augmented antibacterial activity
promoted by HAp as a carrier. This agrees with our previous finding of enhanced antimicrobial
efficacy of clindamycin against intracellular colonies of S. aureus following the delivery of the
drug using HAp nanoparticles as the carrier67. In this study, too, we see that the delivery of
vancomycin using HAp nanoparticles can significantly augment the efficacy of the antibiotic per
se. This is especially interesting when it is noted that vancomycin is an antibiotic with little to no
efficacy against gram-negative bacteria in the first place68.
Finally, experiments assessing the interaction of the pastes with healthy cells indicated that
the addition of the vancomycin-carrying composite pastes to cultured hMSCs had no negative
effects on their viability. As seen from Fig.13, no reduction in viability was observed in cultures
treated with the composite HAp pastes containing either 19.4 or 26.5 wt.% gelatin. Additionally,
the composite pastes were more abundantly uptaken by the hMSCs than pure HAp. As shown in
Fig.14f, the uptake of the composite paste was three times higher than that of pure HAp. This
effect in theory favors the use of the composite paste as a gene carrier over pure HAp and may be
due to a greater degree of cohesiveness in the composite paste, which prevents the dissipation of
particles optimally sized for the uptake (~ 200 nm, Fig.1b) into overly fine, sub-20-nm sized HAp
units (Fig.2a). Another possibility is that gelatin engages in interaction with Endo180, a member
of the mannose receptor family, which activates the endocytic uptake pathway in fibroblastic cells
and facilitates the cellular internalization of the material69. Endo180 is a urokinase plasminogen
activator receptor-associated protein that is expressed in all bone-forming tissues, mature and
immature70. It binds through its fibronectin type II domain to both native and denatured collagens
and activates their uptake via a clathrin-dependent pathway71. A more passive effect contributing
to the grater uptake of gelatin-containing particles may be also due to their larger adhesiveness in
contact with the cell surface compared to pure HAp. Furthermore, endocytic uptake pathways
could be triggered indirectly, thanks to the nonspecific binding of gelatin to integrins α2β1 and
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α3β1, discoidin domain receptors, glycoprotein VI, collagen scavenger or other cell membrane
receptors72,73. Meanwhile, no morphological abnormalities were detected in hMSCs following
their treatment with either pure HAp (Fig.14b-c) or the composite paste (Fig.14d-e) when
compared to the untreated control (Fig.14a). This selectivity exhibited by the pastes, toxic for the
bacteria and harmless for the primary stem cells, is a promising property when it comes to their
consideration for application as bone grafts in the treatment of osteomyelitis.

Fig.13. hMSC viability following the treatment with the vancomycin-loaded composite HAp-gelatin-silica pastes
containing different amounts of gelatin: 19.4 and 26.5 wt.%. Bars represent averages, while error bars are standard
deviations. No statistically significant difference (p < 0.05) is detected between any of the sample groups.
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Fig.14. Confocal fluorescent optical images showing hMSCs subjected to no treatment (a) and challenged with either
a pure HAp paste (b-c) or a composite HAp-gelatin-silica paste. Cells were stained for nucleus (blue) and f-actin
cytoskeletal microfilaments (red), while the nanomaterial was stained in green. Data in (f) represent a difference in
the amount of uptaken material per cell and are shown as averages with error bars representing standard deviation.
The asterisk denotes an extremely statistically significant difference (P < 0.001).

4. Conclusion
In this study we report on a bioresorbable composite material that is compact, yet flowing
upon injection; that promotes antibacterial activity while being harmless to healthy cells; that
forms pores large enough to accommodate cells inside its structure following immersion in body
fluids; and that sets under physiological conditions in a tunable manner and in clinically relevant
time windows, ranging from 1 to 3 minutes at its fastest, while delaying the setting under ambient
conditions. In spite of these promising properties, the composite pastes display deficiencies that
must be solved, including, most critically, the weak mechanical properties and phase segregation
during flow. The former, mechanical stability issue is tied to the unanswered problem of
integration of HAp crystals into collagen fibers on the nano scale, without which no replication of
the mechanical properties of bone is possible. Therefore, introduction of a proper bridging agent,
acting as a link between CP crystals and gelatin and ensuring a uniform bonding conformation,
may be a next logical step in the design of these composites. The stability issue during flow, in
turn, has origins in the inherently weak colloidal stability of CP nanoparticles, caused in part by
their inherently low zeta potentials and in part by the highly hydrated and diffusive surface that
fosters Ostwald ripening and other forms of aggregational growth. It calls for the use of appropriate
surfactants, though such that will not interfere with the particle-particle contact on which the
successful setting reaction depends. Integration of stable porogens, whose dissolution would create
interconnected pores in the material while sustaining the macroporous structure against its
tendency to collapse and crumble, is another tremendous challenge that needs to be solved.
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The findings of this study fall along the line of effort to use nanoparticles to augment the
activity of pharmacotherapies that may have lost or never had any efficacy against certain
pathologies. Specifically, we have shown that composite CP pastes can increase the activity of
antibiotics compared to the antibiotic therapy alone. This includes the types of bacteria resistant to
the delivered antibiotic, vancomycin, because of their outer membrane impermeability to it.
Observation of this effect, which may be due to the bacterial cell wall disruption enabled by CP
nanoparticles, reinforces our belief that CP nanoparticles present a viable carrier of antibiotics for
a range of infections, extending beyond the realm of bone and other hard tissues. These findings
are expected to be a rivulet transformable into a grand stream of effort to augment or completely
eliminate the need for pharmacologically active molecules by utilizing the knowledge of materials
chemistry to rationally design nanoparticulate materials with well-defined biomedical properties.
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